Sunday, March 15, 2026

A case of a classic penile chancre

 

       

Case Summary: 18-year-old white male with a classic penile chancre present for 1 week, highly suggestive of primary syphilis; focus should be on confirming diagnosis with appropriate serologic testing and initiating stage-appropriate treatment and partner management.


          Workup Plan


Assessment Summary

18-year-old male with a 1-week history of a classic penile chancre: solitary, likely painless, indurated ulcer with regional lymphadenopathy. Timing and morphology are highly suggestive of primary syphilis. No information given to suggest neurologic, ocular, or otologic involvement. Main goals: confirm/solidify diagnosis, initiate definitive therapy today, address partners and STI co-risk, and set up long-term monitoring.


Differential Diagnosis / Working Diagnosis

Working diagnosis:

  • Primary syphilis due to Treponema pallidum.

Key differentials for genital ulcer (lab confirmation still needed):

  • Genital HSV (more often painful, multiple grouped vesicles → shallow ulcers).
  • Chancroid (painful, ragged ulcer with tender suppurative nodes; uncommon in many regions).
  • Traumatic ulcer.
  • Fixed drug eruption.
  • Less likely: LGV, granuloma inguinale, aphthous/Behçet (if systemic/oral ulcers).

Given the classic solitary painless indurated chancre and epidemiology, treat as primary syphilis today while completing confirmatory testing.


Workup Plan

Laboratory Studies (obtain today)

  1. Syphilis serology (baseline and confirmation)

    • Quantitative RPR or VDRL (with titer):
      • For baseline staging and future comparison.
      • Document exact titer and the lab used.
    • Treponemal test per lab algorithm:
      • Either treponemal EIA/CIA (with reflex RPR) or TP-PA as confirmatory.
    • If treponemal positive but RPR negative:
      • Order second treponemal test (e.g., TP-PA) to clarify.
    • If clinical picture is classic but tests are negative:
      • Repeat serology in 2–4 weeks (early window), but do not delay treatment.
  2. Direct detection from chancre (if available)

    • Darkfield microscopy of chancre exudate, or
    • PCR for T. pallidum from lesion swab.
    • Rationale: improves sensitivity very early, when serology might still be negative.
  3. HIV and STI screening

    • HIV 4th-generation Ag/Ab test today.
      • Plan to repeat at 3 months if initial negative and ongoing risk.
    • GC/CT NAAT:
      • Urine NAAT.
      • Consider rectal and pharyngeal NAAT depending on sexual practices.
    • Hepatitis B and C:
      • HBsAg, anti-HBs, anti-HBc to determine infection/immunity and need for vaccination.
      • HCV Ab (especially if risk factors present).
    • Consider syphilis serology in partners (as part of partner services; see below).
  4. Basic assessment for neurosyphilis/ocular/otologic involvement

    • Focused symptom review:
      • Headache, neck stiffness, visual changes, eye pain, hearing loss, tinnitus, vertigo, focal neurologic deficits, psychiatric/behavioral changes.
    • If any positive → different pathway (see “Red Flags”).

Imaging

  • None routinely indicated in uncomplicated primary syphilis without neuro/ocular signs.

Procedures

  • No biopsy needed if classic chancre and positive/confirmatory testing pathway for syphilis is in place.
  • Lumbar puncture:
    • Not indicated in uncomplicated primary syphilis without neurologic/ocular/otologic symptoms.
    • Reserve for red-flag scenarios (see below).

                 Treatment Plan

Medications (start today)

  1. First-line therapy (preferred)

    • Benzathine penicillin G (Bicillin L-A)
      • Dose: 2.4 million units IM once, given as two 1.2 million unit injections in separate gluteal sites.
      • Confirm product is Bicillin L-A only (NOT Bicillin C-R).
  2. Penicillin allergy (non-pregnant; if history present)

    • If no pregnancy and adherence plus follow-up are reliable:
      • Doxycycline 100 mg PO BID for 14 days,
        OR
      • Tetracycline 500 mg PO QID for 14 days (less commonly used).
    • Alternative (if oral adherence concern or GI intolerance, and after discussion/ID input):
      • Ceftriaxone 1 g IM/IV once daily for 10 days.
    • Avoid azithromycin due to resistance.
    • If allergy is severe and adherence uncertain, or if other complicating factors:
      • Consider penicillin desensitization and standard benzathine penicillin regimen.
  3. Symptomatic management

    • For Jarisch–Herxheimer reaction or chancre discomfort:
      • Acetaminophen or NSAIDs as needed.
    • Local hygiene and comfort measures (see Topicals/Local care).

Topical / Local Treatments

  • Keep the penile lesion:
    • Clean and dry; gentle washing with mild soap and water.
    • Avoid:
      • Topical antibiotics (usually unnecessary and can irritate).
      • Topical corticosteroids on the ulcer.
      • Harsh antiseptics.
  • Loose, breathable underwear to reduce friction and moisture.

Procedures

  • None required beyond injection of benzathine penicillin G.

Lifestyle Modifications / Risk Reduction

  • Sexual abstinence:
    • No sexual activity (oral, vaginal, anal) until:
      • At least 7 days after treatment, AND
      • The chancre has fully healed.
  • Condom use:
    • After resuming sexual activity, consistent condom use to reduce risk of syphilis reinfection and other STIs.
  • Substance use:
    • Assess and counsel if substance use is contributing to high-risk sexual behavior.

Patient Education

Discuss clearly, in understandable language:

  1. Diagnosis and course

    • Explain that the lesion is highly consistent with primary syphilis.
    • Syphilis is a sexually transmitted infection that progresses through stages but is highly curable at this stage.
    • The chancre often heals on its own in weeks, but infection persists and can progress without treatment.
  2. Testing and follow-up

    • Blood tests today will:
      • Confirm the infection.
      • Provide a baseline titer (RPR/VDRL), which will be used to check that treatment worked.
    • Results do not change the need to treat now, given the classic appearance.
  3. Treatment specifics

    • One-time penicillin injection today is the gold standard treatment.
    • Stress: this is benzathine penicillin G (Bicillin L-A), a long-acting formulation specifically for syphilis.
    • Emphasize the importance of completing the full course if an alternative oral regimen (e.g., doxycycline) is used.
  4. Jarisch–Herxheimer reaction

    • Possible within 24 hours of starting therapy:
      • Fever, chills, headache, muscle aches, worsening of lesions for a brief period.
    • This is:
      • A reaction to dying bacteria, not a drug allergy.
      • Usually mild, resolving within 24 hours.
    • Management: rest, fluids, acetaminophen/NSAIDs.
    • When to seek care: very high fever, confusion, difficulty breathing, or if unsure.
  5. Infectiousness and sexual partners

    • Syphilis is very contagious when ulcers are present.
    • Everyone with whom he has had sex in the last 90 days should be:
      • Notified, tested, and presumptively treated for early syphilis, even if tests are negative.
    • Explain that partner treatment protects him and others and is a standard medical and public health practice.
    • Clarify that public health may help anonymously with partner notification, where available.
  6. HIV and STI risk

    • Having syphilis increases both risk of acquiring and transmitting HIV.
    • Discuss:
      • HIV testing now and repeat at 3 months if at risk.
      • HIV PrEP as an option if he has ongoing high-risk exposures.
    • Explain testing for gonorrhea, chlamydia, and hepatitis and potential need for hepatitis B vaccination and HPV vaccination (if not up to date).
  7. Long-term monitoring

    • Blood test (RPR/VDRL) at 6 and 12 months is essential to:
      • Confirm the infection has responded appropriately.
      • Detect possible reinfection.
    • Emphasize the need to return even if feeling well.

Follow-up Schedule

  1. Short-term (1–2 weeks)

    • Visit or telehealth check:
      • Review initial lab results (syphilis serology, HIV, GC/CT, hepatitis).
      • Confirm the chancre is improving/healing.
      • Reinforce abstinence/condom use and partner notification.
      • Address any side effects or Jarisch–Herxheimer reaction that may have occurred.
  2. Intermediate (3 months)

    • If initial HIV test negative and ongoing risk:
      • Repeat HIV 4th-gen.
    • Consider repeat STI screening (GC/CT, syphilis) if high-risk ongoing exposures.
  3. Serologic follow-up (syphilis titers)

    • 6 months:
      • Repeat quantitative RPR/VDRL using the same test and same lab as baseline.
      • Expect at least a 4-fold decline (e.g., from 1:32 to ≤1:8) by 6–12 months; a clear downward trend should be evident.
    • 12 months:
      • Repeat RPR/VDRL:
        • Document ≥4-fold decline from baseline.
    • 24 months:
      • Consider an additional titer in high-risk patients, those with HIV infection, or if follow-up adherence is uncertain.
  4. Additional visits

    • As needed for new symptoms, new exposures, or if titers do not decline as expected.

Red Flags / When to Return Sooner

Instruct the patient to seek urgent or same-day care if any of the following occur:

  1. Neurologic, ocular, or otologic symptoms

    • New or worsening:
      • Severe headache, neck stiffness.
      • Visual changes (blurred or double vision, eye pain, vision loss).
      • Hearing loss, ringing in the ears (tinnitus), vertigo.
      • Weakness, numbness, difficulty walking, changes in speech.
      • Confusion, personality changes, memory issues.
    • These raise concern for neurosyphilis or ocular/otologic syphilis and may require:
      • Ophthalmology/neurology evaluation.
      • CSF examination (lumbar puncture).
      • IV penicillin therapy.
  2. Severe reaction after treatment

    • Markedly high fever (>39–40°C), rigors, severe malaise that does not improve within 24–48 hours.
    • Shortness of breath, wheezing, throat swelling, or hives (concern for anaphylaxis/allergic reaction, not Jarisch–Herxheimer).
    • Any symptom that makes him feel acutely ill or unsafe at home.
  3. New or worsening skin or mucosal lesions

    • New rashes on the body, palms/soles.
    • Oral ulcers, wart-like lesions in the genital or perianal area (condyloma lata).
    • Persistent or worsening penile ulcer beyond 4 weeks after treatment.
  4. Signs of treatment failure or reinfection

    • New genital ulcers or symptoms after initial healing.
    • A new sexual exposure followed by symptoms.
  5. Psychosocial / adherence issues

    • Difficulty taking prescribed doxycycline (if used).
    • Trouble attending appointments or contacting partners—encourage early communication so the care team and/or public health can help problem-solve.

Applied Summary for This Patient Today

  • Diagnose/Treat now: Treat as primary syphilis today with benzathine penicillin G 2.4 MU IM x1 (Bicillin L-A).
  • Order labs: Baseline RPR (with titer), treponemal test (EIA/CIA or TP-PA), darkfield/PCR from chancre if available, HIV 4th-gen, GC/CT NAAT (urine ± sites by exposure), hepatitis B and C panel; review vaccination status (HBV, HPV).
  • Counsel: Abstinence until 7 days post-treatment and chancre fully healed; explain Jarisch–Herxheimer reaction; discuss partner notification for last 90 days and public health involvement; discuss HIV risk and possible PrEP evaluation if appropriate.
  • Follow-up: Schedule 1–2 week visit, and RPR titers at 6 and 12 months (same lab), with HIV retest at 3 months if indicated.

No comments:

Post a Comment

A case of a classic penile chancre

          Case Summary: 18-year-old white male with a classic penile chancre present for 1 week, highly suggestive of primary syphilis; fo...